Prestige Consumer Healthcare (PBH) Cash from Investing Activities (2010 - 2025)

Prestige Consumer Healthcare's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$128.6 million for Q4 2025.

• On a quarterly basis, Cash from Investing Activities fell 1209.7% year-over-year to -$128.6 million in Q4 2025; TTM through Dec 2025 was -$136.9 million, a 372.46% decrease from a year earlier, with the FY2025 full-year figure at -$17.5 million, up 13.22% from the prior year.
• Cash from Investing Activities eased to -$128.6 million in Q4 2025 per PBH's latest filing, from -$2.9 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $2.3 million in Q2 2023 and bottomed at -$231.7 million in Q3 2021.
• The 5-year median for Cash from Investing Activities is -$3.1 million (2022), against an average of -$22.2 million.
• Across the five-year window, Cash from Investing Activities tumbled 2455.33% in 2021 and soared 321.87% in 2023, its largest moves.
• Year by year, Cash from Investing Activities stood at -$20.2 million in 2021, then surged by 91.09% to -$1.8 million in 2022, then tumbled by 149.36% to -$4.5 million in 2023, then tumbled by 118.33% to -$9.8 million in 2024, then sank by 1209.7% to -$128.6 million in 2025.
• Per Business Quant, the three latest PBH Cash from Investing Activities figures stand at -$128.6 million (Q4 2025), -$2.9 million (Q3 2025), and -$1.9 million (Q2 2025).